Literature DB >> 4804280

Macrophage electrophoretic migration (MEM) test for lymphocyte sensitization: some practical experiences in macrophage selection.

B K Shenton, D Hughes, E J Field.   

Abstract

Mesh：

Substances：

Year:  1973        PMID： 4804280      PMCID： PMC2149042     

Source DB:  PubMed          Journal:  Br J Cancer Suppl        ISSN： 0306-9443


× No keyword cloud information.
  4 in total

1.  Macrophage-electrophoretic-mobility (M.E.M.) test for malignant disease. An independent confirmation.

Authors:  J A Pritchard; J L Moore; W H Sutherland; C A Joslin
Journal:  Lancet       Date:  1972-09-23       Impact factor: 79.321

2.  Demonstration of sensitized lymphocytes in blood.

Authors:  E J Field; E A Caspary
Journal:  J Clin Pathol       Date:  1971-03       Impact factor: 3.411

3.  Lymphocyte sensitisation: an in-vitro test for cancer?

Authors:  E J Field; E A Caspary
Journal:  Lancet       Date:  1970-12-26       Impact factor: 79.321

4.  Evaluation and development of the macrophage electrophoretic mobility (MEM) test for malignant disease.

Authors:  J A Pritchard; J L Moore; W H Sutherland; C A Joslin
Journal:  Br J Cancer       Date:  1973-01       Impact factor: 7.640
  4 in total
  11 in total

1.  Letter: Diagnostic test for multiple sclerosis.

Authors:  E J Filed; B K Shenton
Journal:  Br Med J       Date:  1975-01-11

2.  Non-specificity of laboratory test for diagnosis of multiple sclerosis.

Authors:  J Mertin; D Hughes; E A Caspary; A M Thomson; J B Foster; E G Stewart-Wynne
Journal:  Br Med J       Date:  1974-12-07

3.  Scrapie: a review of its relation to human disease and ageing.

Authors:  E J Field
Journal:  J Med Genet       Date:  1976-12       Impact factor: 6.318

4.  [The electrophoretic-mobility-(EM) test: a method for discrimination of malignant and non-malignant tumors (author's transl)].

Authors:  C Tautz; W Schneider; E Laier; G Brügmann
Journal:  Klin Wochenschr       Date:  1978-02-15

5.  [The macrophage electrophoretic mobility LAD test - a diagnostic method for multiple sclerosis.].

Authors:  H Meyer-Rienecker; H L Jenssen; H Köhler; J K Günther
Journal:  J Neurol       Date:  1976-02       Impact factor: 4.849

6.  [Demonstration of a factor in cerebrospinal fluid with inhibitory activity for electrophoretic cell mobility in multiple sclerosis (author's transl)].

Authors:  H L Jenssen; H J Meyer-Rienecker; H Werner
Journal:  J Neurol       Date:  1976-11-26       Impact factor: 4.849

7.  Erythrocyte-UFA (Eufa) mobility test for multiple sclerosis: implications for pathogenesis and handling of the disease.

Authors:  E J Field; G Joyce; B M Smith
Journal:  J Neurol       Date:  1977-01-13       Impact factor: 4.849

8.  A common tumour-specific antigen: III. Preparation of small fragments incorporating the cell-sensitizing determinant.

Authors:  J P Dickinson; J R McDermott; J K Smith; E A Caspary
Journal:  Br J Cancer       Date:  1980-08       Impact factor: 7.640

9.  Responses of cancer patients in the MEM test: not just a function of charge on basic proteins.

Authors:  A Shaw; G Ettin; T A McPherson
Journal:  Br J Cancer       Date:  1976-07       Impact factor: 7.640

10.  Clinical assessment of the MOD-MEM cancer test in controls with non-malignant diseases.

Authors:  J A Pritchard; J L Moore; W H Sutherland; C A Joslin
Journal:  Br J Cancer       Date:  1976-07       Impact factor: 7.640
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.